Mirati Therapeutics

$158.19
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$5.86 (-3.57%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell MRTX and other stocks, options, and ETFs commission-free!

About MRTX

Mirati Therapeutics, Inc. operates as a clinical-stage oncology company, which engages in the development of novel therapeutics. The firm's products targets the genetic and immunological promoters of cancer.

CEO
Charles M. Baum
Employees
201
Headquarters
San Diego, California
Founded
1995
Market Cap
7.80B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
374.46K
High Today
$164.76
Low Today
$154.93
Open Price
$164.76
Volume
554.37K
52 Week High
$249.42
52 Week Low
$80.36

MRTX Earnings

-$2.08
-$1.39
-$0.69
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 6, After Hours

You May Also Like

NDEKY
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure